References
- PfeifferNDorzolamide: development and clinical application of a topical carbonic anhydrase inhibitorSurv Ophthalmol1997421371519381367
- KonowalAMorrisonJCBrownSVIrreversible corneal decompensation in patients treated with topical dorzolamideAm J Ophthalmol199912740340610218692
- DigiuniMFogagnoloPRossettiLA review of the use of latanoprost for glaucoma since its launchExpert Opin Pharmacother20121372374522348427
- ErdoganHOzecAVCanerCTokerMIAriciMKTopalkaraAEffect of latanoprost/timolol and dorzolamide/tiomolol on intraocular pressure after phacoemulsification surgeryInt J Ophthalmol2011419019422553640
- DelaneyYMSalmonJFMossaFPeriorbital dermatitis as a side effect of topical dorzolamideBr J Ophthalmol20028637838011914202
- KlugerNGuillotBRaison-PeyronNSystemic contact dermatitis to dorzolamide eye dropsContact Dermatitis20085816716818279155
- KalavalaMStathamBNAllergic contact dermatitis from timolol and dorzolamide eye dropsContact Dermatitis20065434516787459
- Linares MataTPardo SánchezJde la Cuadra OyangurenJContact dermatitis caused by allergy to dorzolamideContact Dermatitis20055211111215725294
- MancusoGBerdondiniRMAllergic contact blepharoconjunctivitis from dorzolamideContact Dermatitis20014524311683843
- ShimadaMHigakiYKawashimaMAllergic contact dermatitis due to dorzolamide eyedropsContact Dermatitis2001455211422277
- Aalto-KorteKContact allergy to dorzolamide eyedropsContact Dermatitis1998392069817238